Open an account

Innovate

VATE · NYSE

$5.92−$0.03 (−0.50%)TodayMarket closed ·
Prev close $5.95

About VATE

INNOVATE Corp. is a diversified holding company, which engages in the acquisition and investment of assets. The company is headquartered in New York City, New York and currently employs 3,587 full-time employees. The company went IPO on 2011-06-23. The firm has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. The company provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. The company owns and operates broadcast television stations throughout the United States.

Employees
3,663
Headquarters
New York City, New York
Listed
Jun 23, 2011
Sector
Industrials
Industry
Construction & Engineering
Website
innovatecorp.com

VATE key statistics

Market cap
81.85M
Price-earnings ratio
0.00
Dividend yield
2.19%
Average volume
63.32K
Volume
65.61K
Open price
$5.83
High today
$6.03
Low today
$5.76
52 Week high
$21.30
52 Week low
$3.75

Innovate (VATE) at a glance

As of Oct 20, 2026, Innovate (VATE) shares are priced at $5.92, giving the company a market cap of 81.85M, a price-to-earnings ratio of 0.00 and a dividend yield of 2.19%.

Today the stock has traded between $5.76 and $6.03. The current price is 2.8% above the day's low and 1.8% below its high.

Volume so far is 65.61K shares, in line with the average of 63.32K shares a day.

Over the past year Innovate has ranged from $3.75 to $21.30, and now sits 12% of the way up that range.

Innovate met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q1 FY26 it reported -$1.29 per share against an estimate of $0.00.

VATE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 0.0% on average.

  1. Q3 FY23: reported -$0.09 per share against an estimate of $0.00
  2. Q4 FY23: reported -$0.12 per share against an estimate of $0.00
  3. Q1 FY24: reported -$0.22 per share against an estimate of $0.00
  4. Q2 FY24: reported $0.10 per share against an estimate of $0.00
  5. Q4 FY24: reported -$1.29 per share against an estimate of $0.00
  6. Q1 FY25: reported -$1.89 per share against an estimate of $0.00
  7. Q2 FY25: reported -$1.67 per share against an estimate of $0.00
  8. Q1 FY26: reported -$1.29 per share against an estimate of $0.00

VATE news

  • 12 Industrials Stocks Moving In Monday's Intraday Session

  • 12 Industrials Stocks Moving In Friday's Intraday Session

  • 12 Industrials Stocks Moving In Friday's Pre-Market Session

  • Mohd Haider

    Innovate Stock Soars Over 42% Overnight: Here's What You Need to Know

  • 12 Industrials Stocks Moving In Thursday's After-Market Session

  • Innovate Q1 2026 Earnings Call Transcript

  • 12 Industrials Stocks Moving In Monday's Intraday Session

  • 12 Industrials Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as Innovate

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.